methyl 2-(4-trifluoromethylphenyl)cyclopent-1-enecarboxylate | 220652-92-6

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: methyl 2-(4-trifluoromethylphenyl)cyclopent-1-enecarboxylate
• 英文别名: Methyl 2-[4-(trifluoromethyl)phenyl]-1-cyclopentene-1-carboxylate；methyl 2-[4-(trifluoromethyl)phenyl]cyclopentene-1-carboxylate
• CAS: 220652-92-6
• 化学式: C₁₄H₁₃F₃O₂
• 分子量: 270.251
• InChiKey: AEVNNZOQAVQHBA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  19
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  二甲氧基-[4-(三氟甲基)苯基]硼烷 在 盐酸 、 tris-(dibenzylideneacetone)dipalladium(0) 、 sodium hydroxide 作用下， 以 四氢呋喃 、 水 、 甲苯 为溶剂， 反应 4.0h， 生成 methyl 2-(4-trifluoromethylphenyl)cyclopent-1-enecarboxylate
  参考文献：
  名称：

  铃木-Miyaura交叉偶联和铱催化的不对称加氢对映异构合成顺式1,2-二取代的环戊烷和环己烷

  摘要：

  通过Suzuki-Miyaura将2-溴-1-环己烯甲醛或2-羰甲氧基-1-环己烯-1-基三氟甲磺酸酯与芳基硼酸酯的交叉偶联制备了一系列1,2-二取代的环己烯衍生物。这些四取代的环状烯烃经过Ir催化的不对称氢化反应。通过使用膦基甲基恶唑啉作为配体，以这种方式以高收率获得了具有高对映选择性和非对映选择性（高达> 99％ee，> 99％ 顺式）的顺-1-甲氧基甲基-2-芳基环己烷 。Suzuki-Miyaura交叉偶合制备的类似环戊烯衍生物的不对称氢化被证明更困难，并且对映体选择性较低，最高可达88％  ee。这种交叉偶联/不对称氢化策略的合成潜力通过手性六氢芴酮的对映选择性途径得到证明。

  DOI：

  10.1002/chem.201102650

文献信息

• Heterocyclic amide compounds as apolipoprotein b inhibitors
  申请人：Takasugi Hisashi

  公开号：US20050038035A1

  公开（公告）日：2005-02-17

  The present invention relates to a compound of the formula (I) wherein R 1 is optionally substituted aryl; R 2 is optionally substituted aryl, optionally substituted heteroaryl, optionally substituted lower cycloalkyl, optionally substituted aryloxy, optionally substituted arylsulfonyl, vinyl, carbamoyl, protected carboxy or protected amino; ring A is bivalent residue derived from optionally substituted aryl or optionally substituted heteroaryl; X is bivalent residue derived from the group consisting of cycloalkene, naphthalene, unsaturated 5 or 6-membered heteromonocyclic group, each of which is optionally substituted, and substituted benzene; Y is -(A 1 ) m1 -(A 2 ) m2 -; and Z is direct bond or piperazine, or a salt thereof. The compound of the present invention and a salt thereof inhibit apolipoprotein B (Apo B) secretion and are useful as a medicament for prophylactic and treatment of diseases or conditions resulting from elevated circulating levels of Apo B.

  本发明涉及一种化合物，其分子式为（I），其中R1为可选取代芳基；R2为可选取代芳基、可选取代杂环芳基、可选取代较低环烷基、可选取代芳氧基、可选取代芳基磺酰基、乙烯基、氨基甲酰基、保护羧基或保护氨基；环A为由可选取代芳基或可选取代杂环芳基衍生的二价残基；X为由环烷烯、萘、不饱和的5或6元杂单环基衍生的二价残基，每种残基均可选取代，以及取代苯基；Y为-(A1)m1-(A2)m2-；Z为直接键或哌嗪，或其盐。本发明的化合物及其盐能抑制载脂蛋白B（Apo B）的分泌，并可用作预防和治疗由于高循环Apo B水平引起的疾病或病症的药物。
• HETEROCYCLIC AMIDE COMPOUNDS AS APOLIPOPROTEIN B INHIBITORS
  申请人：FUJISAWA PHARMACEUTICAL CO., LTD.

  公开号：EP1472226A1

  公开（公告）日：2004-11-03
• [EN] HETEROCYCLIC AMIDE COMPOUNDS AS APOLIPOPROTEIN B INHIBITORS<br/>[FR] COMPOSES D'AMIDE HETEROCYCLIQUES EN TANT QU'INHIBITEURS DE L'APOLIPOPROTEINE B
  申请人：FUJISAWA PHARMACEUTICAL CO

  公开号：WO2003045921A1

  公开（公告）日：2003-06-05

  The present invention relates to a compound of the formula (I) wherein R1 is optionally substituted aryl; R2 is optionally substituted aryl, optionally substituted heteroaryl, optionally substituted lower cycloalkyl, optionally substituted aryloxy, optionally substituted arylsulfonyl, vinyl, carbamoyl, protected carboxy or protected amino; ring A is bivalent residue derived from optionally substituted aryl or optionally substituted heteroaryl; X is bivalent residue derived from the group consisting of cycloalkene, naphthalene, unsaturated 5 or 6-membered heteromonocyclic group, each of which is optionally substituted, and substituted benzene; Y is -(A1)m1-(A2)m2-; and Z is direct bond or piperazine, or a salt thereof. The compound of the present invention and a salt thereof inhibit apolipoprotein B (Apo B) secretion and are useful as a medicament for prophylactic and treatment of diseases or conditions resulting from elevated circulating levels of Apo B.
• Enantioselective Synthesis of cis-1,2-Disubstituted Cyclopentanes and Cyclohexanes by Suzuki-Miyaura Cross-Coupling and Iridium-Catalyzed Asymmetric Hydrogenation
  作者：Andreas Schumacher、Marcus G. Schrems、Andreas Pfaltz

  DOI：10.1002/chem.201102650

  日期：2011.11.25

  using phosphinomethyloxazolines as ligands. Asymmetric hydrogenation of analogous cyclopentene derivatives, prepared by Suzuki–Miyaura cross‐coupling, proved to be more difficult and proceeded with lower enantioselectivities of up to 88 % ee. The synthetic potential of this cross‐coupling/asymmetric‐hydrogenation strategy was demonstrated by an enantioselective route to chiral hexahydrofluorenones.

  通过Suzuki-Miyaura将2-溴-1-环己烯甲醛或2-羰甲氧基-1-环己烯-1-基三氟甲磺酸酯与芳基硼酸酯的交叉偶联制备了一系列1,2-二取代的环己烯衍生物。这些四取代的环状烯烃经过Ir催化的不对称氢化反应。通过使用膦基甲基恶唑啉作为配体，以这种方式以高收率获得了具有高对映选择性和非对映选择性（高达> 99％ee，> 99％ 顺式）的顺-1-甲氧基甲基-2-芳基环己烷 。Suzuki-Miyaura交叉偶合制备的类似环戊烯衍生物的不对称氢化被证明更困难，并且对映体选择性较低，最高可达88％  ee。这种交叉偶联/不对称氢化策略的合成潜力通过手性六氢芴酮的对映选择性途径得到证明。